383 related articles for article (PubMed ID: 28581406)
1. Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
Su TS; Liang P; Liang J; Lu HZ; Jiang HY; Cheng T; Huang Y; Tang Y; Deng X
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):639-646. PubMed ID: 28581406
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis.
Yang JF; Lo CH; Lee MS; Lin CS; Dai YH; Shen PC; Chao HL; Huang WY
Radiat Oncol; 2019 Oct; 14(1):180. PubMed ID: 31640728
[TBL] [Abstract][Full Text] [Related]
3. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.
Nakano R; Ohira M; Kobayashi T; Ide K; Tahara H; Kuroda S; Shimizu S; Kimura T; Nagata Y; Aikata H; Chayama K; Ohdan H
Surgery; 2018 Aug; 164(2):219-226. PubMed ID: 29801728
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis.
Sun J; Wang Q; Hong ZX; Li WG; He WP; Zhang T; Zhang AM; Fan YZ; Sun YZ; Zheng L; Duan XZ
Hepatol Int; 2020 Sep; 14(5):788-797. PubMed ID: 32886334
[TBL] [Abstract][Full Text] [Related]
5. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study.
Takahara T; Wakabayashi G; Beppu T; Aihara A; Hasegawa K; Gotohda N; Hatano E; Tanahashi Y; Mizuguchi T; Kamiyama T; Ikeda T; Tanaka S; Taniai N; Baba H; Tanabe M; Kokudo N; Konishi M; Uemoto S; Sugioka A; Hirata K; Taketomi A; Maehara Y; Kubo S; Uchida E; Miyata H; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):721-7. PubMed ID: 26096910
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.
Ruzzenente A; Guglielmi A; Sandri M; Campagnaro T; Valdegamberi A; Conci S; Bagante F; Turcato G; D'Onofrio M; Iacono C
J Gastrointest Surg; 2012 Feb; 16(2):301-11; discussion 311. PubMed ID: 22095524
[TBL] [Abstract][Full Text] [Related]
7. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study.
Troisi RI; Berardi G; Morise Z; Cipriani F; Ariizumi S; Sposito C; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Russolillo N; Wilson GC; Cimino M; Montalti R; Giglio MC; Igarashi K; Chan CY; Torzilli G; Cheung TT; Mazzaferro V; Kaneko H; Ferrero A; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Aldrighetti L; Yamamoto M
Br J Surg; 2021 Mar; 108(2):196-204. PubMed ID: 33711132
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.
Guarneri A; Franco P; Trino E; Campion D; Faletti R; Mirabella S; Gaia S; Ragona R; Diotallevi M; Saracco G; Salizzoni M; Ricardi U; Carucci P
Med Oncol; 2016 Oct; 33(10):104. PubMed ID: 27566310
[TBL] [Abstract][Full Text] [Related]
10. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma.
Takeda A; Sanuki N; Eriguchi T; Kobayashi T; Iwabutchi S; Matsunaga K; Mizuno T; Yashiro K; Nisimura S; Kunieda E
J Gastroenterol Hepatol; 2014 Feb; 29(2):372-9. PubMed ID: 23927053
[TBL] [Abstract][Full Text] [Related]
12. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
14. Repeated stereotactic ablative radiotherapy using CyberKnife for patients with hepatocellular carcinoma.
Lo CH; Huang WY; Lin KT; Lin MJ; Lin TP; Jen YM
J Gastroenterol Hepatol; 2014 Nov; 29(11):1919-25. PubMed ID: 25041220
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
16. Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma.
Sposito C; Battiston C; Facciorusso A; Mazzola M; Muscarà C; Scotti M; Romito R; Mariani L; Mazzaferro V
Br J Surg; 2016 Jun; 103(7):871-80. PubMed ID: 27029597
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function.
Kang CM; Choi GH; Kim DH; Choi SB; Kim KS; Choi JS; Lee WJ
J Surg Res; 2010 May; 160(1):81-9. PubMed ID: 19577249
[TBL] [Abstract][Full Text] [Related]
18. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis.
Ma KW; Chok KSH; She WH; Chan ACY; Cheung TT; Dai WC; Fung JYY; Lo CM
Liver Transpl; 2018 Aug; 24(8):1062-1069. PubMed ID: 29451360
[TBL] [Abstract][Full Text] [Related]
19. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis.
Paul S; Lee PC; Mao J; Isaacs AJ; Sedrakyan A
BMJ; 2016 Jul; 354():i3570. PubMed ID: 27400862
[TBL] [Abstract][Full Text] [Related]
20. Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.
Paik EK; Kim MS; Jang WI; Seo YS; Cho CK; Yoo HJ; Han CJ; Park SC; Kim SB; Kim YH
Radiat Oncol; 2016 Feb; 11():22. PubMed ID: 26896371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
